Introduction {#sec1-1}
============

Alzheimer\'s disease (AD) is the most common cause of dementia in the elderly people is characterized by disturbance of multiple cortical functions, including memory loss, judgement, orientation, comprehension, learning capacity, and language deficit.\[[@ref1][@ref2]\] The major symptoms of all type of dementia are presumed to be related to progressive deterioration of widespread and dense cholinergic innervation of the human cerebral cortex, which contributes to the cognitive and behavioral disturbances in AD, and is also associated with the decreased levels of the neurotransmitter, acetylcholine (ACh), choline acetyltransferase, and acetylcholinesterase (AChE).\[[@ref3]\] Apart from AChE, ACh is also hydrolytically destroyed in the brain by another enzyme, butyrylcholinesterase (BuChE).\[[@ref4]\] In the healthy brain, AChE is the most important enzyme regulating the levels of ACh, while BuChE plays a minor role. In patient with AD, the levels of AChE activity declines and the activity of BuChE increases and the ratio between BuChE and AChE can change from 0.6 in the normal brain to as high as 11 in the cortical areas affected the disease.\[[@ref5]\] These observations lead to dual inhibition strategy of these enzymes has been proposed to increase the efficacy of treatment and broaden the indications.

The medicinal use of garlic and several Indian medicinal plants were demonstrated by more than 1,300 research articles during the past 100 years.\[[@ref6][@ref7]\] This background and the fact that garlic is also described as having immunomodulatory, anti-inflammatory, and antioxidant effects. This focused our interest on the question of whether the known constituents of processed garlic specifically allicin (\[R, S\]-diallyl disulfide-S-oxide) on inhibition of AChE and BuChE, two important enzymes involved in the breakdown of ACh in the human brain.\[[@ref8]\] In the present study, we investigated the inhibitory effects of allicin on AChE and BuChE enzymes.

Materials and Methods {#sec1-2}
=====================
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### Chemicals/Reagents {#sec3-1}

AChE (EC 3.1.1.7) and BuChE (EC 3.1.1.8) from bovine erythrocytes, acetylthiocholine iodide (ATChI), butyrylthiocholine iodide, 5:5-dithiobis-2-nitrobenzoic acid (DTNB), and sodium bicarbonate were purchased from Sigma, UK. Allicin (Triveni Ltd). The extraction procedure was carried out as described in a previously published study.\[[@ref9]\]
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### Cholinesterase Assays {#sec3-2}

An assessment of cholinesterase inhibition was carried out *in vitro* in flat-bottom 96-well microtiter plates using a Ellman\'s colorimetric method.\[[@ref10][@ref11]\] A typical run consisted of 5 μL of bovine AChE/BuChE solution, at final assay concentrations of 0.03 U/mL; 200 μL of 0.1 M phosphate buffer pH 8; 5 μL of DTNB at a final concentration of 0.3 mM prepared in 0.1 M phosphate buffer pH 7 with 0.12 M of sodium bicarbonate; and 5 μL of the test solution. The reactants were mixed and preincubated for 15 min at 30°C. The reaction was initiated by adding 5 μL of ATChI/BuChI at final concentrations of 0.5 mM. As a control, the inhibitor solution was replaced with buffer. The control and test samples were assayed in triplicate. To monitor any nonenzymatic hydrolysis in the reaction mixture, two blanks for each run were prepared in triplicate. One blank consisted of buffer replacing enzyme and a second blank had buffer replacing substrate. Change in absorbance at 405 nm was measured on a molecular device M2, 96-well plate reader for a period of 6 min at 30°C.

Results {#sec1-3}
=======
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### Estimation of IC~50~ Value of Allicin {#sec3-3}

The result showed that allicin inhibited the AChE in a concentration-dependent manner at different concentrations tested (0.003 mg/mL to 0.1 mg/mL) \[[Figure 1](#F1){ref-type="fig"}\], a concentration of 0.1 mg/mL showed maximum inhibition which was 95%. The IC~50~ value was 0.01 ± 0.009 mg/mL (61.62 μM) derived from equation of [Figure 1](#F1){ref-type="fig"}. This result demonstrated that allicin was a potent AChE inhibitor. In contrast to AChE inhibition, allicin also inhibited BuChE enzyme, but the inhibition was not as strong compared with AChE. The concentration of allicin tested in the range of 0.003--0.1mg/mL, showed percentage inhibition ranging from 16% to 56%, respectively. The maximum inhibition was observed at the concentration of 0.1 mg/mL (56%) \[[Figure 2](#F2){ref-type="fig"}\]. The IC~50~ concentration calculated was 0.05 ± 0.018 mg/mL (308.12 μM) from the equation of [Figure 2](#F2){ref-type="fig"}. The results showed that allicin was a weak BuChE inhibitor.
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### Statistical Analysis {#sec3-4}

Data obtained were subjected to Windows 7 (Microsoft office) version 2007, mean, ± standard error of the mean, and IC~50~ was calculated using Windows 7 (Microsoft Excel software).

Discussion {#sec1-4}
==========

Garlic (*Allium sativum*) has been used worldwide by Egyption, Chinese, and Indians as a spice, food, and folk medicine for centuries. It has been used to treat various ailments such as heart disease, arthritis, pulmonary complaints, cancer, diarrhea, and worm infestation.\[[@ref12]\] Several investigators have reported different medicinal uses of garlic, one of these is its anti-oxidative properties, which not only protect against oxidative damage but also lower the risk of injury to vital molecules and to varying degree may help prevent the onset and progression of age-related neurodegenerative diseases.\[[@ref13][@ref14]\] Studies of senile dementia model in mice showed that aged garlic extract prevented atrophic changes in the frontal brain, improved learning abilities and memory retention, and increased longevity in the senescence-accelerated mouse.\[[@ref15][@ref16]\]

Allicin is reported to have most active lipid-soluble volatile organosulfur biological compound present in the freshly crushed garlic.\[[@ref17]\] It was demonstrated earlier that *Torpedo californiac* AChE when incubated with allicin produced rapid inactivation which was time and concentration dependent.\[[@ref18]\] Our results which showed concentration-dependent inhibition of bovine AChE by allicin complementing the previous finding. According to our knowledge, we are for the first time reporting the concentration-dependent inhibition of BuChE by allicin. Although several cholinesterase inhibitors such as tacrine, rivastigmine, and donepezil are being used for management of conditions associated with AD, their side effects have become increasingly noticeable.\[[@ref19][@ref20]\] Therefore, the therapy with these newer derivatives obtained from the natural product that have dual function and lesser adverse effects could be beneficial for AD patients.

In summary, it\'s demonstrated that allicin strongly inhibit AChE but weakly inhibit BuChE in a concentration-dependent manner. These results may provide an interesting basic contribution with regard to the beneficial effects claimed for garlic and may be of therapeutic value in AD. However, further study on the pharmacological and *in vivo* behavioral test is needed. Thus, this active compound has a potential to ameliorate the decline of cognitive function and memory loss associated with AD.
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